AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 APR 1 - (NewsRx.com & NewsRx.net) -- Conceptus, Inc., (CPTS) announced that Planned Parenthood Federation of America (PPFA) has approved the company's nonincisional permanent birth control procedure Essure for use in qualifying Planned Parenthood Affiliates across the United States.
PPFA has nearly 900 clinics under 123 PPFA affiliates that serve nearly 5 million people a year.
"We are very pleased that PPFA's thorough evaluation demonstrated that Essure can safely and effectively be offered in a clinic setting," said Mark Sieczkarek, president and CEO of Conceptus. "Working with Planned Parenthood is of vital importance to our goal of making sure all women have access to Essure, including those who do not have private insurance coverage."
PPFA tested the Essure procedure in clinics in Oregon and Pennsylvania, evaluating the ability of a typical clinic setting to successfully offer the procedure. Standards for the use of Essure in PPFA affiliates were then developed along with guidelines for the introduction of the procedure into Planned Parenthood clinic settings.
"Essure represents a completely new way for Planned Parenthood to meet women's reproductive health and family planning needs," said Vanessa Cullins, vice president, medical affairs for PPFA. "With the advent of this exciting medical breakthrough a large number of Planned Parenthood clinics in the U.S. ...